1Anon. A predictive model for aggressive non-Hodgkin's lymphonla. The international non-Hodgkin's lymphoma prognostic factors project[J]. N Engl J Med. 1993. 329(14): 987-994.
3Appelbaum FR, Deissemth AB, Graw RG Jr, et al. Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse [J]. Cancer. 1978.41(3): 1059-1063.
4Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non- Hodgkin's lymphoma [J]. N Engl J Med. 1995. 333(23): 1540-1545.
5Bertz H, Zeiser R, Lange W. et al. Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognoslic Index[J]. Ann Oncol. 2004, 15(9): 1419-1424.
6Rodriguez J, Conde E, Gutierrez A. eta]. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lyrnphoma and Autologous Transplantation Group experience [J]. Ann Oncol, 2007. 18(4): 652-657.
7Gopal AK, Metealfe TL, Gooley TA, el al. High-dose therapy and autologous stem cell transplantation for ehemoresistant hodgkln lymphoma: the seattle experience [J]. Cancer, 2008, 113(6): 1344-1350.
8Linch DC, Wiufield D, Goldstone AH, et al. Dose intensifieatiou with ABMT in relapsed and resistant Hodgkin's disease.resuhs of a BNLI randomised trial[J]. Lancet, 1993, 341(8852): 1051-1054.
9Schmitz N, Pfistner B, Sextro M, et al. Aggressive conventional ehemotherapy compared with high-dose ehemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial [J]. Lancet. 2002, 359(9323): 2065-2071.
10Majhail NS, Weisdorf DJ. Detbr TE, et al. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma[J]. Biol Blood Marrow Transplant. 2006. 12(10): 1065-1072.
二级参考文献10
1Carella A M,Prencipe E,Pungolino E,et al.Twelve years′ experience with high-dos therapy and autologous stem cell transplantation for high-risk Hodgkin′s disease patients in first remission after MOPP ABVD protocol[].Leukemia and Lymphoma.1996
2Sehn L H,Antin J H,Shulman L N,et al.Primary diffuse large B-cell lymphoma of the mediastinum: outcome following highdose chemotherapy and autologous hematopoietic cell transplantation[].Blood.1998
3Gianni A M,Bregni M,Siena S,et al.High-dose chemotherapy and autologous bone marrow transplantation comparde with MACOP-B in aggressive B-cell lymphoma[].The New England Journal of Medicine.1997
4Phillips G L,Wolff S N,Herzig R H,et al.Treatment of progressive Hodgkin′s disease with intensive chemoradiotherapy and autologous bone marrow transplantation[].Blood.1989
5Phillip T,Gomez F,Guglielmi C,et al.Long-term outcome of relapsed non-Hodgkin′s Lymphoma ( NHL) patients included in the PARMA trial : Incidence of late relapses, long-term toxicity and impact of ther International Prognostice Index ( IPI ) at relapse[].Proceedings of the American Society of Clinical Oncology.1998
6Popat V,Van Beisen K,Amin K,et al.Autologous transplantation is curative treatment for patients with recurrent and refractory primary mediastinal lymphoma[].Blood.1996
7Sureda A,Mataix R,Hernandez-Navarro F,et al.Autologous stem cell transplantation for poor prognosis Hodgkin′s disease in first complete remission: A retrospective study from the Spanish GEL-TAMO cooperative group[].Bone Marrow Transplantation.1997
8Reece D E,Barnett M J,Shepherd J D,et al.High-dose sequential chemoradiotherapy with peripheral blood progeniter cell support for relapsed or refractory Hodgkin′s disease: A 6yrar update[].Annals of Oncology.1993
9Bierman P J,Anderson J R,Freeman M B,et al.High dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin′s disease patients following first relapse after chemotherapy[].Annals of Oncology.1996
10Sweeten ham J W,Liberti G,Pearce R,et al.High-dose therapy and autogous bone marrow transplantation for adult patients with lymphoblastic lymphoma: Results of the European Group for Bone Marrow Transplantation[].Journal of Clinical Oncology.1994
2Rapoport A P, Meisenberg B, Sarkodee-Adoo C, et al. Autotransplan-tation for advanced lymphoma and Hodgkin , s disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemo-therapy [J]. Bone Marrow Transplant, 2002, 29(4) ; 303 -312.
4Larouche J F,Berger F,Chassagne-Clement C,et al. Lymphoma re-currence 5 years or later following diffuse large B-cell lymphoma : clini-cal characteristics and outcome [ J]. J Clin Oncol, 2010, 28(12):2094-2100.
5Gross T G, Hale G A, He W, et al. Hematopoietic stem cell transplanta-tion for refractory or recurrent non-Hodgkin lymphoma in children and ado-lescents [J]. Biol Blood Marrow Transplant, 2010, 6(2) : 223 - 230.
6Rodriguez J, Conde E, Gutierrez A, et al. The results of consolida-tion with autologous stem-cell transplantation in patients with peripher-al T-cell lymphoma (PTCL) in first complete remission : the SpanishLymphoma and Autologous Transplantation Group experience [ J].Ann Oncol, 2007,18(4) : 652 -657.
7Wada N, Kohara M, Ogawa H, et al. Change of CD20 Expression inDiffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody : A Study of the Osaka Lymphoma StudyGroup[ J]. Case Rep Oncol, 2009,2(3) : 194 -202.
8Sorror M L, Storer B E, Maloney D G, ei al. Outcomes after alloge-neic hematopoietic cell transplantation with nonmyeloablative or mye-loablative conditioning regimens for treatment of lymphoma and chron-ic lymphocytic leukemia [ J]. Blood, 2008, 111(1) : 446 -452.
9Pieris A, Ascanj S, Leoneini L, et al. Hodgkin's lymphoma:the pathologist's viewpoint. J Clin Pathol, 2002, 55: 162-176.
10Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's disease. N Engl J Med, 1998, 339: 1506-1514.
